William LaRochelle
12Patents
5h-index
40Co-inventors
62Inventor score
Filing activity: Jun 25, 1993 → Jan 20, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6403769B1 | Fusion proteins that include antibody and nonantibody portions | Chemistry; Metallurgy | 29 | Expired |
| US5468468A | Method for making a monoclonal antibody, monoclonal antibodies to .alpha. P D | Physics | 18 | Expired |
| US5833986A | Methods of inhibiting the growth of neoplasia using a monoclonal antibody against .alpha. platelet derived growth factor receptor | Physics | 11 | Expired |
| US5998598A | Immunoadhesins and methods of production and use thereof | Chemistry; Metallurgy | 10 | Expired |
| US5863739A | Assay and kit for the detection of .alpha. platelet derived growth factor receptor | Physics | 6 | Expired |
| US7253266B2 | Polypeptides of FGF-CX | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8846873B2 | Antibodies directed to GPNMB and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US7056885B1 | Fibroblast growth factor and nucleic acids encoding same | Human Necessities | 5 | Expired |
| US6863889B2 | Polynucleotides and proteins encoded thereby | Human Necessities | 4 | Expired |
| US6368828B1 | Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and Stat6c | Chemistry; Metallurgy | 4 | Expired |
| US5573935A | Protein tyrosine kinase A6 | Chemistry; Metallurgy | 3 | Expired |
| US7189693B2 | Treatment of inflammatory bowel disease using fibroblast growth factor CX polypeptides | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.